Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

HIV/AIDS : Welcome to Medscape HIV/AIDS, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles, and trending stories.

Gilead Sciences, Inc. (GILD) on Wednesday announced a strategic partnership agreement with the Global Fund to combat AIDS, Tuberculosis, and Malaria by supplying doses of its HIV prevention injection ...

BANGOR -- Lubec’s Regional Healthcare Center has discontinued all it’s HIV service programs. For years, the Regional Medical Center at Lubec has provided outreach counseling, testing, and referrals ...

The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens.

There are many diseases that mosquitoes can transmit, but HIV isn't one of them. Here's why, and what viruses you do need to watch out for depending on where you live.

Lenacapavir, the first FDA-approved, twice-yearly injectable PrEP for HIV prevention, shows 96% efficacy and offers ...